20 10-6 group independently developed the first Chinese medicine with independent intellectual property rights-Keluoxin capsule, which was included in the national key new product plan of 20 10 by the Ministry of Science and Technology. 20 10-6-3 kanghong pharmaceutical group was awarded the license by the national intellectual property pilot unit of enterprises and institutions. According to the document number 20 10-4. National Science and Technology Bureau 20 10068, four members of Kanghong Pharmaceutical Group (Chengdu Kanghong Pharmaceutical Group Co., Ltd., Chengdu Kanghong Pharmaceutical Co., Ltd., Chengdu Kanghong Biotechnology Co., Ltd., Sichuan Jishengtang Pharmaceutical Co., Ltd.) successfully passed the publicity of the Ministry of Science and Technology and obtained the high-tech enterprise certificate. On April 5, 2009, the trademark of Kanghong Pharmaceutical Group was recognized as a well-known trademark in China by the Trademark Office of the State Administration for Industry and Commerce. 2009- 1-7 Kanghong Pharmaceutical Group won the 30-year Innovation Award of China Pharmaceutical Reform and Opening-up. 2008- 10-2 1 China Chemical and Pharmaceutical Industry Association awarded the group AAA enterprise credit rating certificate. As the first batch of AAA credit evaluation units of pharmaceutical enterprises, the Group is also the only credit enterprise in our province. On September 2, 2008, the All-China Federation of Trade Unions awarded Kang Hong Guangcai the honorary title of Worker Pioneer of the digital film and television disaster relief love propaganda team. At the same time, Ke Zunhong, Chairman and President of the Group, was awarded the honorary certificate of 5. 12 earthquake relief. 2008-4- 1 1 China chemical pharmaceutical industry association awarded the honorary title of the 6th advanced member unit of China chemical pharmaceutical industry association, and the group is also the only enterprise in the western region to receive this honor. On September 20, 2007, the National Development and Reform Commission issued Announcement No.50 in 2007, which publicized the evaluation score of the National Enterprise Technology Center, and Kanghong Pharmaceutical Group successfully passed the evaluation. In September 2006, the Group Technology Center was recognized as a national enterprise technology center by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs and State Taxation Administration of The People's Republic of China. In 2006-2, the group was awarded the certificate of enterprise director of China Hospital Association by China Hospital Association; May 2005: Ganke Shuangqing Capsule of Sichuan Jishengtang Pharmaceutical Co., Ltd. was awarded the national torch project certificate by the Torch High-tech Industry Development Center of the Ministry of Science and Technology; In May 2005, Bosiqing, Chengdu Southwest Pharmaceutical Co., Ltd., was awarded the national torch plan project certificate by the Torch High-tech Industry Development Center of the Ministry of Science and Technology; In May 2005, Chengdu Kanghong Pharmaceutical Co., Ltd. Songling Xuemaikang Capsule was awarded the National Torch Program Project Certificate by Torch High-tech Industry Development Center of Ministry of Science and Technology; 2005- 1 Chengdu kanghong pharmaceutical co., ltd W 198 won the first prize of scientific and technological progress of the Ministry of education of People's Republic of China (PRC) (PRC) 2004- 12 Chengdu southwest pharmaceutical co., ltd aripiprazole tablets won the project certificate of technological innovation fund for small and medium-sized scientific and technological enterprises of the technological innovation fund management center of the Ministry of science and technology; In May 2004, Chengdu Southwest Pharmaceutical Co., Ltd. Xinluona was awarded the national torch project certificate by the Torch High-tech Industry Development Center of the Ministry of Science and Technology; July 2003: Verona, Chengdu Southwest Pharmaceutical Co., Ltd., was awarded the project certificate of SME Technology Innovation Fund by the Technology Innovation Fund Management Center of the Ministry of Science and Technology; In April 2003, Yiqing Capsule of Chengdu Kanghong Pharmaceutical Co., Ltd. was awarded the certificate of protected varieties of traditional Chinese medicine by the State Food and Drug Administration of the United States. In July 2000, Songling Xuemaikang Capsule and Zhenkening Capsule were awarded the national second-class protected varieties of traditional Chinese medicine from 2000 to May, and Bailena was awarded the national new product certificate in 2000 by the State Economic and Trade Commission. 1998- 1 1 Bolexin, a new chemical drug of Chengdu Southwest Pharmaceutical Co., Ltd., was awarded the title of national key new product by the Ministry of Science and Technology of the People's Republic of China and State Taxation Administration of The People's Republic of China. 1996- 1 Chengdu kanghong pharmaceutical co., ltd Songling xuemaikang capsule was awarded the gold medal of the first Canadian international Chinese medicine acupuncture exhibition by the academic Committee of the first Canadian international Chinese medicine acupuncture exhibition1996;